查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1404644

細胞重編程市場規模、佔有率、趨勢分析報告：按技術、應用、最終用途、地區和細分市場預測，2024-2030 年

Cell Reprogramming Market Size, Share & Trends Analysis Report By Technology (Episomal Reprogramming, mRNA Reprogramming), By Application (Therapeutic, Research), By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 119 Pages | 商品交期: 2-10個工作天內

價格

細胞重編程市場成長與趨勢：

根據Grand View Research, Inc.最新報告，預計到2030年，全球細胞重編程市場規模將達到6.642億美元，2024年至2030年複合年成長率為8.52%。

癌症研究中擴大採用細胞重編程以及對細胞重編程的日益關注等因素預計將推動市場成長。此外，對主要企業之間的合作研究和夥伴關係的重視預計將促進市場成長。 mRNA 重編程技術的進步使得能夠利用身體組織快速、安全、有效率地產生臨床級人類 iPS 細胞。此外，由於 mRNA 較小，因此轉染過程比其他重編程載體更容易。當使用難以重編程的樣本時，mRNA重編程可將重編程效率提高1%。

此外，此方法可以更快速、更安全地從人體組織產生高品質的人類iPS細胞，增加了對mRNA重編程技術的需求。它還具有將人類幹細胞重新編程到原始狀態的能力，使它們能夠重現其最早的發育階段。例如，2022 年 3 月，巴布拉漢姆研究所的研究人員發現了促進此初始化過程的關鍵因素。這項新發現為研究人員簡化並加速了幼稚多功能能幹細胞的生成。此外，在政府和公共資金的大力支持下，細胞重編程正在不斷發展。這種支持是對其為醫療保健領域帶來的各種好處的回應，特別是在潛在的醫療應用方面。

此外，研究人員最近已將細胞重編程從實驗室重新定位到臨床。這種變化在各種臨床和學術研究中都很引人注目，包括再生醫學、疾病建模以及與藥物毒性和藥物研發相關的研究。細胞重編程的臨床效用在再生醫學中尤其明顯。研究和學術機構領域的成長推動了旨在透過細胞重編程開發創新產品的策略性舉措的增加。例如，加州再生醫學研究所資助研究小組將細胞重編程推進臨床重點治療應用。

細胞重編程市場報告亮點

  • 由於易於使用、速度快、安全和高效，同時從身體組織產生高品質的人類 iPS 細胞，mRNA 重編程技術細分市場在 2023 年佔據最大的銷售佔有率，為 32.67%。
  • 研究應用領域在 2023 年以 67.41% 的佔有率引領市場。成長的主要驅動力之一是利用幹細胞進行細胞重編程領域的持續研究。
  • 2023 年，研究和學術最終用途領域佔銷售佔有率 67.41%。這種成長歸因於細胞重編程在各種臨床和學術研究計劃中的使用，包括再生治療、疾病建模和藥物毒性/藥物研發研究。
  • 由於該地區主要參與者的存在，北美在 2023 年佔據全球行業的主導地位，銷售額佔有率為 38.65%。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章市場變數、趨勢和範圍

  • 市場體系展望
  • 市場動態
  • 產業分析工具

第4章科技業務分析

  • 細胞重編程市場：技術波動分析
  • 用仙台病毒重新編程
  • mRNA重編程
  • 遊離重編程
  • 其他

第5章 應用業務分析

  • 細胞重編程市場：應用變異分析
  • 研究
  • 治療

第6章 最終用途業務分析

  • 細胞重編程市場：最終用途變異分析
  • 研究和學術機構
  • 生物技術和製藥公司

第7章 區域業務分析

  • 2022 年及 2030 年細胞重編程市場佔有率（按地區）
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲

第8章競爭形勢

  • 公司分類
  • 策略規劃
  • 2022 年企業市場分析
  • 公司簡介/名單
    • Thermo Fisher Scientific, Inc.
    • Allele Biotech
    • ALSTEM
    • STEMCELL Technologies Inc.
    • Merck KGaA
    • Bio-Techne
    • REPROCELL
    • Lonza
    • FUJIFILM Corporation（Fujifilm Cellular Dynamics）
    • Mogrify Limited
Product Code: GVR-4-68039-966-2

Cell Reprogramming Market Growth & Trends:

The global cell reprogramming market size is expected to reach USD 664.2 million by 2030, according to a new report by Grand View Research, Inc., growing at a CAGR of 8.52% from 2024 to 2030. Factors, such as increasing adoption of cell reprogramming in cancer research and growing focus on cell reprogramming, are expected to drive market growth. In addition, emphasis on collaborations and partnerships among key players is anticipated to boost market growth. Advancements in the mRNA reprogramming technique allow rapid, safe, and efficient generation of clinical-grade human iPS cells using somatic tissue. In addition, as mRNA is lower in size, the transfection process is simpler than other reprogramming vectors. When utilizing difficult-to-reprogram samples, mRNA reprogramming improves reprogramming efficiency by 1%.

Furthermore, this method can generate high-quality human iPS cells from somatic tissue more rapidly and safely, which increases the demand for mRNA reprogramming technology. Furthermore, there is the capability to reprogram human stem cells back to a naive state, allowing replication of the earliest developmental stages. For instance, in March 2022, researchers at the Babraham Institute identified key factors facilitating this reprogramming process. This new knowledge streamlines and expedites the generation of naive pluripotent stem cells for researchers. Moreover, cell reprogramming is experiencing growth due to significant government and public funding. This backing is a response to various benefits it offers to the healthcare sector, particularly in terms of its potential applications in medicine.

Furthermore, cell reprogramming has recently been repositioned from the lab to clinic by researchers. This shift is prominent in various clinical & academic research initiatives, encompassing regenerative medicine, disease modeling, and studies related to medication toxicity & drug discovery. The clinical utility of cell reprogramming, especially in regenerative medicine, has been significant. Increased strategic initiatives aimed at innovative product development through cell reprogramming is due to a growth in the research and academic institute segment. For instance, the California Institute for Regenerative Medicine funded research groups to advance cellular reprogramming into therapeutic applications with a clinical focus.

Cell Reprogramming Market Report Highlights:

  • The mRNA reprogramming technology segment held the largest revenue share of 32.67% in 2023 due to the ease of use, speed, safety, and efficiency while generating high-quality human iPS cells from somatic tissue
  • The research application segment led the market with a share of 67.41% in 2023. One of the main factors driving its growth include ongoing research in the field of cell reprogramming using stem cells
  • The research & academic institute end-use segment held a revenue share of 67.41% in 2023. The growth is due to usage of cell reprogramming in a various clinical & academic research initiatives, including those involving regenerative therapies, disease modeling, and drug toxicity/drug discovery studies
  • North America dominated the global industry in 2023 with a revenue share of 38.65% owing to the presence of key players in this region

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Information Analysis
    • 1.2.2. Market Platform & Data Visualization
    • 1.2.3. Data Validation & Publishing
  • 1.3. Research Assumptions
  • 1.4. Information Procurement
    • 1.4.1. Primary Research
  • 1.5. Information or Data Analysis
  • 1.6. Market Platform & Validation
  • 1.7. Market Model
  • 1.8. Global Market: CAGR Calculation
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Growing focus on cell reprogramming
      • 3.2.1.2. Increasing adoption of cell reprogramming in cancer research
      • 3.2.1.3. Emphasis on collaborations and partnerships among key players
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Challenges associated with iPSCs
      • 3.2.2.2. Limited awareness regarding treatment option
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Technology Business Analysis

  • 4.1. Cell Reprogramming Market: Technology Movement Analysis
  • 4.2. Sendai Virus-based Reprogramming
    • 4.2.1. Sendai Virus-based Reprogramming Market, 2018 - 2030 (USD Million)
  • 4.3. mRNA Reprogramming
    • 4.3.1. mRNA Reprogramming Market, 2018 - 2030 (USD Million)
  • 4.4. Episomal Reprogramming
    • 4.4.1. Episomal Reprogramming Market, 2018 - 2030 (USD Million)
  • 4.5. Others
    • 4.5.1. Others Reprogramming Market, 2018 - 2030 (USD Million)

Chapter 5. Application Business Analysis

  • 5.1. Cell Reprogramming Market: Application Movement Analysis
  • 5.2. Research
    • 5.2.1. Research Market, 2018 - 2030 (USD Million)
  • 5.3. Therapeutics
    • 5.3.1. Therapeutics Market, 2018 - 2030 (USD Million)

Chapter 6. End-use Business Analysis

  • 6.1. Cell Reprogramming Market: End-use Movement Analysis
  • 6.2. Research & Academic Institutes
    • 6.2.1. Research & Academic Institutes Market, 2018 - 2030 (USD Million)
  • 6.3. Biotechnology & Pharmaceutical Companies
    • 6.3.1. Biotechnology & Pharmaceutical Companies Market, 2018 - 2030 (USD Million)

Chapter 7. Regional Business Analysis

  • 7.1. Cell Reprogramming Market Share By Region, 2022 & 2030
  • 7.2. North America
    • 7.2.1. North America Cell Reprogramming Market, 2018 - 2030 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. Key Country Dynamics
      • 7.2.2.2. Competitive Scenario
      • 7.2.2.3. U.S. Cell Reprogramming Market, 2018 - 2030 (USD Million)
    • 7.2.3. Canada
      • 7.2.3.1. Key Country Dynamics
      • 7.2.3.2. Competitive Scenario
      • 7.2.3.3. Canada Cell Reprogramming Market, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe Cell Reprogramming Market, 2018 - 2030 (USD Million)
    • 7.3.2. UK
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. Competitive Scenario
      • 7.3.2.3. UK Cell Reprogramming Market, 2018 - 2030 (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Competitive Scenario
      • 7.3.3.3. Germany Cell Reprogramming Market, 2018 - 2030 (USD Million)
    • 7.3.4. France
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Competitive Scenario
      • 7.3.4.3. France Cell Reprogramming Market, 2018 - 2030 (USD Million)
    • 7.3.5. Italy
      • 7.3.5.1. Key Country Dynamics
      • 7.3.5.2. Competitive Scenario
      • 7.3.5.3. Italy Cell Reprogramming Market, 2018 - 2030 (USD Million)
    • 7.3.6. Spain
      • 7.3.6.1. Key Country Dynamics
      • 7.3.6.2. Competitive Scenario
      • 7.3.6.3. Spain Cell Reprogramming Market, 2018 - 2030 (USD Million)
    • 7.3.7. Denmark
      • 7.3.7.1. Key Country Dynamics
      • 7.3.7.2. Competitive Scenario
      • 7.3.7.3. Denmark Cell Reprogramming Market, 2018 - 2030 (USD Million)
    • 7.3.8. Sweden
      • 7.3.8.1. Key Country Dynamics
      • 7.3.8.2. Competitive Scenario
      • 7.3.8.3. Sweden Cell Reprogramming Market, 2018 - 2030 (USD Million)
    • 7.3.9. Norway
      • 7.3.9.1. Key Country Dynamics
      • 7.3.9.2. Competitive Scenario
      • 7.3.9.3. Norway Cell Reprogramming Market, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Cell Reprogramming Market, 2018 - 2030 (USD Million)
    • 7.4.2. Japan
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. Japan Cell Reprogramming Market, 2018 - 2030 (USD Million)
    • 7.4.3. China
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. China Cell Reprogramming Market, 2018 - 2030 (USD Million)
    • 7.4.4. India
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. India Cell Reprogramming Market, 2018 - 2030 (USD Million)
    • 7.4.5. Australia
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Competitive Scenario
      • 7.4.5.3. Australia Cell Reprogramming Market, 2018 - 2030 (USD Million)
    • 7.4.6. Thailand
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Competitive Scenario
      • 7.4.6.3. Thailand Cell Reprogramming Market, 2018 - 2030 (USD Million)
    • 7.4.7. South Korea
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Competitive Scenario
      • 7.4.7.3. South Korea Cell Reprogramming Market, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America Cell Reprogramming Market, 2018 - 2030 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Brazil Cell Reprogramming Market, 2018 - 2030 (USD Million)
    • 7.5.3. Mexico
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Mexico Cell Reprogramming Market, 2018 - 2030 (USD Million)
    • 7.5.4. Argentina
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Argentina Cell Reprogramming Market, 2018 - 2030 (USD Million)
  • 7.6. MEA
    • 7.6.1. MEA Cell Reprogramming Market, 2018 - 2030 (USD Million)
    • 7.6.2. South Africa
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. South Africa Cell Reprogramming Market, 2018 - 2030 (USD Million)
    • 7.6.3. Saudi Arabia
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Saudi Arabia Cell Reprogramming Market, 2018 - 2030 (USD Million)
    • 7.6.4. UAE
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. UAE Cell Reprogramming Market, 2018 - 2030 (USD Million)
    • 7.6.5. Kuwait
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Competitive Scenario
      • 7.6.5.3. Kuwait Cell Reprogramming Market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Position Analysis, 2022
  • 8.4. Company Profiles/Listing
    • 8.4.1. Thermo Fisher Scientific, Inc.
      • 8.4.1.1. Overview
      • 8.4.1.2. Financial Performance
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. Allele Biotech
      • 8.4.2.1. Overview
      • 8.4.2.2. Financial Performance
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. ALSTEM
      • 8.4.3.1. Overview
      • 8.4.3.2. Financial Performance
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Strategic Initiatives
    • 8.4.4. STEMCELL Technologies Inc.
      • 8.4.4.1. Overview
      • 8.4.4.2. Financial Performance
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. Merck KGaA
      • 8.4.5.1. Overview
      • 8.4.5.2. Financial Performance
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. Bio-Techne
      • 8.4.6.1. Overview
      • 8.4.6.2. Financial Performance
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Strategic Initiatives
    • 8.4.7. REPROCELL
      • 8.4.7.1. Overview
      • 8.4.7.2. Financial Performance
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Strategic Initiatives
    • 8.4.8. Lonza
      • 8.4.8.1. Overview
      • 8.4.8.2. Financial Performance
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Strategic Initiatives
    • 8.4.9. FUJIFILM Corporation (Fujifilm Cellular Dynamics)
      • 8.4.9.1. Overview
      • 8.4.9.2. Financial Performance
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Strategic Initiatives
    • 8.4.10. Mogrify Limited
      • 8.4.10.1. Overview
      • 8.4.10.2. Financial Performance
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
  • Table 4 Global Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
  • Table 5 Global Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
  • Table 6 Global Cell Reprogramming Market, By Region, 2018 - 2030 (USD Million)
  • Table 7 North America Cell Reprogramming Market, By Country, 2018 - 2030 (USD Million)
  • Table 8 North America Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
  • Table 9 North America Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
  • Table 10 North America Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
  • Table 11 U.S. Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
  • Table 12 U.S. Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
  • Table 13 U.S. Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
  • Table 14 Canada Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
  • Table 15 Canada Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
  • Table 16 Canada Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
  • Table 17 Europe Cell Reprogramming Market, By Country, 2018 - 2030 (USD Million)
  • Table 18 Europe Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
  • Table 19 Europe Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
  • Table 20 Europe Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
  • Table 21 UK Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
  • Table 22 UK Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
  • Table 23 UK Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
  • Table 24 Germany Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
  • Table 25 Germany Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
  • Table 26 Germany Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
  • Table 27 France Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
  • Table 28 France Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
  • Table 29 France Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
  • Table 30 Spain Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
  • Table 31 Spain Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
  • Table 32 Spain Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
  • Table 33 Italy Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
  • Table 34 Italy Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
  • Table 35 Italy Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
  • Table 36 Denmark Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
  • Table 37 Denmark Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
  • Table 38 Denmark Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
  • Table 39 Norway Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
  • Table 40 Norway Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
  • Table 41 Norway Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
  • Table 42 Sweden Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
  • Table 43 Sweden Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
  • Table 44 Sweden Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
  • Table 45 Asia Pacific Cell Reprogramming Market, By Country, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
  • Table 49 China Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
  • Table 50 China Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
  • Table 51 China Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
  • Table 52 Japan Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
  • Table 53 Japan Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
  • Table 54 Japan Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
  • Table 55 India Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
  • Table 56 India Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
  • Table 57 India Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
  • Table 58 South Korea Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
  • Table 59 South Korea Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
  • Table 60 South Korea Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
  • Table 61 Australia Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
  • Table 62 Australia Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
  • Table 63 Australia Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
  • Table 64 Thailand Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
  • Table 65 Thailand Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
  • Table 66 Thailand Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
  • Table 67 Latin America Cell Reprogramming Market, By Country, 2018 - 2030 (USD Million)
  • Table 68 Latin America Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
  • Table 69 Latin America Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
  • Table 70 Latin America Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
  • Table 71 Brazil Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
  • Table 72 Brazil Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
  • Table 73 Brazil Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
  • Table 74 Mexico Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
  • Table 75 Mexico Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
  • Table 76 Mexico Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
  • Table 77 Argentina Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
  • Table 78 Argentina Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
  • Table 79 Argentina Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
  • Table 80 MEA Cell Reprogramming Market, By Country, 2018 - 2030 (USD Million)
  • Table 81 MEA Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
  • Table 82 MEA Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
  • Table 83 MEA Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
  • Table 84 South Africa Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
  • Table 85 South Africa Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
  • Table 86 South Africa Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
  • Table 87 UAE Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
  • Table 88 UAE Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
  • Table 89 UAE Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
  • Table 90 Saudi Arabia Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
  • Table 91 Saudi Arabia Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
  • Table 92 Saudi Arabia Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
  • Table 93 Kuwait Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
  • Table 94 Kuwait Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
  • Table 95 Kuwait Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 Cell Reprogramming market segmentation
  • Fig. 8 Market snapshot, 2022
  • Fig. 9 Market trends & outlook
  • Fig. 10 Market driver relevance analysis (current & future impact)
  • Fig. 11 Market restraint relevance analysis (current & future impact)
  • Fig. 12 PESTEL analysis
  • Fig. 13 Porter's five forces analysis
  • Fig. 14 Global cell reprogramming market: Technology outlook and key takeaways
  • Fig. 15 Global cell reprogramming market: Technology movement analysis
  • Fig. 16 Global cell reprogramming market, for sendai virus-based reprogramming, 2018 - 2030 (USD Million)
  • Fig. 17 Global cell reprogramming market, for mRNA reprogramming, 2018 - 2030 (USD Million)
  • Fig. 18 Global cell reprogramming market, for episomal reprogramming, 2018 - 2030 (USD Million)
  • Fig. 19 Global cell reprogramming market, for others, 2018 - 2030 (USD Million)
  • Fig. 20 Global cell reprogramming market: Application outlook and key takeaways
  • Fig. 21 Global cell reprogramming market: Application movement analysis
  • Fig. 22 Global cell reprogramming market, for research, 2018 - 2030 (USD Million)
  • Fig. 23 Global cell reprogramming market, for therapeutic, 2018 - 2030 (USD Million)
  • Fig. 24. Global cell reprogramming market: End-use outlook and key takeaways
  • Fig. 25 Global cell reprogramming market: End-use movement analysis
  • Fig. 26 Global cell reprogramming market, for research & academic institutes, 2018 - 2030 (USD Million)
  • Fig. 27 Global cell reprogramming market, for biotechnology & pharmaceutical companies, 2018 - 2030 (USD Million)
  • Fig. 28 Regional marketplace: Key takeaways
  • Fig. 29 Regional outlook, 2022 & 2030
  • Fig. 30 North America cell reprogramming market, 2018 - 2030 (USD Million)
  • Fig. 31 U.S. Key country dynamics
  • Fig. 32 U.S. cell reprogramming market, 2018 - 2030 (USD Million)
  • Fig. 33 Canada Key country dynamics
  • Fig. 34 Canada cell reprogramming market, 2018 - 2030 (USD Million)
  • Fig. 35 Europe cell reprogramming market, 2018 - 2030 (USD Million)
  • Fig. 36 Germany Key country dynamics
  • Fig. 37 Germany cell reprogramming market, 2018 - 2030 (USD Million)
  • Fig. 38 UK Key country dynamics
  • Fig. 39 UK cell reprogramming market, 2018 - 2030 (USD Million)
  • Fig. 40 France Key country dynamics
  • Fig. 41 France cell reprogramming market, 2018 - 2030 (USD Million)
  • Fig. 42 Italy Key country dynamics
  • Fig. 43 Italy cell reprogramming market, 2018 - 2030 (USD Million)
  • Fig. 44 Spain Key country dynamics
  • Fig. 45 Spain cell reprogramming market, 2018 - 2030 (USD Million)
  • Fig. 46 Denmark Key country dynamics
  • Fig. 47 Denmark cell reprogramming market, 2018 - 2030 (USD Million)
  • Fig. 48 Sweden Key country dynamics
  • Fig. 49 Sweden cell reprogramming market, 2018 - 2030 (USD Million)
  • Fig. 50 Norway Key country dynamics
  • Fig. 51 Norway cell reprogramming market, 2018 - 2030 (USD Million)
  • Fig. 52 Asia Pacific cell reprogramming market, 2018 - 2030 (USD Million)
  • Fig. 53 Japan Key country dynamics
  • Fig. 54 Japan cell reprogramming market, 2018 - 2030 (USD Million)
  • Fig. 55 China Key country dynamics
  • Fig. 56 China cell reprogramming market, 2018 - 2030 (USD Million)
  • Fig. 57 India Key country dynamics
  • Fig. 58 India cell reprogramming market, 2018 - 2030 (USD Million)
  • Fig. 59 Australia Key country dynamics
  • Fig. 60 Australia cell reprogramming market, 2018 - 2030 (USD Million)
  • Fig. 61 South Korea Key country dynamics
  • Fig. 62 South Korea cell reprogramming market, 2018 - 2030 (USD Million)
  • Fig. 63 Thailand Key country dynamics
  • Fig. 64 Thailand cell reprogramming market, 2018 - 2030 (USD Million)
  • Fig. 65 Latin America cell reprogramming market, 2018 - 2030 (USD Million)
  • Fig. 66 Brazil Key country dynamics
  • Fig. 67 Brazil cell reprogramming market, 2018 - 2030 (USD Million)
  • Fig. 68 Mexico Key country dynamics
  • Fig. 69 Mexico cell reprogramming market, 2018 - 2030 (USD Million)
  • Fig. 70 Argentina Key country dynamics
  • Fig. 71 Argentina cell reprogramming market, 2018 - 2030 (USD Million)
  • Fig. 72 Middle East and Africa cell reprogramming market, 2018 - 2030 (USD Million)
  • Fig. 73 South Africa Key country dynamics
  • Fig. 74 South Africa cell reprogramming market, 2018 - 2030 (USD Million)
  • Fig. 75 Saudi Arabia Key country dynamics
  • Fig. 76 Saudi Arabia cell reprogramming market, 2018 - 2030 (USD Million)
  • Fig. 77 UAE Key country dynamics
  • Fig. 78 UAE cell reprogramming market, 2018 - 2030 (USD Million)
  • Fig. 79 Kuwait Key country dynamics
  • Fig. 80 Kuwait cell reprogramming market, 2018 - 2030 (USD Million)